Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...
HSBC analysts on Wednesday downgraded AMD (NASDAQ:AMD) stock to Reduce from Buy, and nearly halved their price target to $110 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback